AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 153 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $223 | -12.5% | 9 | 0.0% | 0.00% | – |
Q2 2023 | $255 | +23.2% | 9 | 0.0% | 0.00% | – |
Q1 2023 | $207 | -18.2% | 9 | 0.0% | 0.00% | – |
Q4 2022 | $253 | – | 9 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 9 | -50.0% | 0.00% | – |
Q1 2021 | $930,000 | – | 18 | +100.0% | 0.00% | – |
Q4 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 9 | -99.0% | 0.00% | -100.0% |
Q4 2019 | $43,000 | +22.9% | 909 | -18.0% | 0.00% | 0.0% |
Q3 2019 | $35,000 | +250.0% | 1,109 | +430.6% | 0.00% | – |
Q2 2019 | $10,000 | +900.0% | 209 | +2222.2% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |